Posts

AFC Women Show Their Support for Brain Health

The Aberdeen FC Women’s team have helped us share an important message about the power of research and the need for better treatments for Alzheimer’s.

Golf and Brain Health: A New Partnership with Big Potential

Scottish Brain Sciences partners with Golf in Society to promote healthy ageing and brain health through the power of golf.

Scottish Brain Sciences joins forces with Aberdeen FC Women

Scottish Brain Sciences is now an Official Partner of Aberdeen FC Women for the 2025/26 season.

Deputy First Minister announces Scottish Brain Sciences as anchor tenant in ONE BioHub Aberdeen

Our CEO, Prof Craig Ritchie, and Chair, Mark Cook, were delighted to meet with Deputy First Minister,Kate Forbes MSP, at our new base in ONE Biohub in Aberdeen.

Speaker sessions from our event – “Can we Prevent and Cure Alzheimer’s Disease?” – are now available!

The fantastic speaker sessions from our first Open Research event are now available to watch on our YouTube channel

SBS webinar event for GPs in Scotland

We hope to create a proactive Scottish network of GPs who want to help their patients become more aware of their current and future brain health.

The SBS Blog – Welcome our new Head of Impact and Innovation!

We are thrilled to be able to welcome Anna Borthwick to the SBS Team as Head of Impact and Innovation! Read more about what she brings to Scottish Brain Sciences…

Hope for the future in dementia research

Read here for an insight from the STV News show, Scotland Tonight, with our CEO and Founder, Prof Craig Ritchie, about the lifechanging potential for research to help detect Alzheimer’s early & treat before it progresses to dementia.

The SBS Blog – Welcome our new Chief Investigator!

Please join us in welcoming Dr Sarah Gregory to the SBS Team as IONA National Coordinator! Read more about what she brings to Scottish Brain Sciences…

Scottish Brain Sciences position on the use of blood-based biomarkers…

Our CEO and Founder, Prof Craig Ritchie, weighs in on blood-based biomarkers for Alzheimer’s disease being openly available to the public in the U.S.